ES2142590T3 - Separacion de hemoglobina no modificada de hemoglobina reticulada. - Google Patents

Separacion de hemoglobina no modificada de hemoglobina reticulada.

Info

Publication number
ES2142590T3
ES2142590T3 ES96918239T ES96918239T ES2142590T3 ES 2142590 T3 ES2142590 T3 ES 2142590T3 ES 96918239 T ES96918239 T ES 96918239T ES 96918239 T ES96918239 T ES 96918239T ES 2142590 T3 ES2142590 T3 ES 2142590T3
Authority
ES
Spain
Prior art keywords
hemoglobin
unmodified
reticulated
separation
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96918239T
Other languages
English (en)
Inventor
William R Light
Maria S Gawryl
Anthony J Laccetti
Robert A Houtchens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biopure Corp
Original Assignee
Biopure Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopure Corp filed Critical Biopure Corp
Application granted granted Critical
Publication of ES2142590T3 publication Critical patent/ES2142590T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

SE DESCRIBE UN METODO PARA SEPARAR HEMOGLOBINA NO MODIFICADA DE HEMOGLOBINA RETICULADA EN UNA SOLUCION DE HEMOGLOBINA. EL METODO IMPLICA PONER EN CONTACTO LA SOLUCION DE HEMOGLOBINA CON AL MENOS UN AGENTE DE DISOCIACION PARA FORMAR UNA SOLUCION DE DISOCIACION EN LA QUE LA HEMOGLOBINA TETRAMERICA NO MODIFICADA SE DISOCIA PARA FORMAR DIMEROS DE HEMOGLOBINA. LOS DIMEROS DE HEMOGLOBINA SE SEPARAN DE LA SOLUCION DE DISOCIACION, A LA VEZ QUE SE RETIENE LA HEMOGLOBINA RETICULADA EN LA SOLUCION DE DISOCIACION.
ES96918239T 1995-06-07 1996-06-05 Separacion de hemoglobina no modificada de hemoglobina reticulada. Expired - Lifetime ES2142590T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/477,916 US5952470A (en) 1995-06-07 1995-06-07 Method for separating unmodified hemoglobin from cross-linked hemoglobin

Publications (1)

Publication Number Publication Date
ES2142590T3 true ES2142590T3 (es) 2000-04-16

Family

ID=23897852

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96918239T Expired - Lifetime ES2142590T3 (es) 1995-06-07 1996-06-05 Separacion de hemoglobina no modificada de hemoglobina reticulada.

Country Status (9)

Country Link
US (3) US5952470A (es)
EP (1) EP0832131B1 (es)
JP (1) JP3950477B2 (es)
AT (1) ATE189819T1 (es)
AU (1) AU6094396A (es)
CA (1) CA2222679C (es)
DE (1) DE69606707T2 (es)
ES (1) ES2142590T3 (es)
WO (1) WO1996040783A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952470A (en) * 1995-06-07 1999-09-14 Biopure Corporation Method for separating unmodified hemoglobin from cross-linked hemoglobin
US6500809B1 (en) 1999-11-12 2002-12-31 Neuron Therapeutics, Inc. Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
WO2001076507A2 (en) 2000-04-11 2001-10-18 The University Of Miami Use of oxygen carriers to improve grafted cell survival in neural transplantation
US20030079015A1 (en) * 2001-05-09 2003-04-24 Dotclick Corporation Method, apparatus and program product providing business processes using media identification and tracking of associated user preferences
WO2006108047A2 (en) * 2005-04-05 2006-10-12 Biopure Corporation Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization
US20090117207A1 (en) * 2005-11-29 2009-05-07 Zoltani Csaba K Methods and compositions for treatment of poison-caused pathology
US20080118572A1 (en) * 2006-10-10 2008-05-22 Harold Richard Hellstrom Methods and compositions for reducing the risk of adverse cardiovascular events associated with the administration of artificial blood
US20110319332A1 (en) * 2010-06-23 2011-12-29 Bing Lou Wong Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) * 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
JP7387597B2 (ja) 2017-07-18 2023-11-28 ヴァーテック・バイオ・インコーポレイテッド ヘモグロビンを含む代用血液及び作製方法
EP3993778A2 (en) 2019-07-02 2022-05-11 HB02 Therapeutics, LLC Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34271A (en) * 1862-01-28 Improvement in shuttles
US32089A (en) * 1861-04-16 Carpet-fastener
USRE32089E (en) * 1970-08-25 1986-03-04 Amicon Corporation Blood fractionating process and apparatus for carrying out same
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US3858014A (en) * 1973-10-19 1974-12-31 G Hughes Gauge and switch diaphragm protector
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4136093A (en) * 1976-04-23 1979-01-23 Biotest-Serum-Institut Gmbh Hemoglobin preparation with increased oxygen release
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4604348A (en) * 1981-11-19 1986-08-05 New York Blood Center, Inc. Composition for use in immunoassays
USRE34271E (en) * 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US5194590A (en) * 1986-06-20 1993-03-16 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5464814A (en) * 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
CA1312009C (en) * 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
ES2032802T5 (es) * 1986-11-10 2004-01-16 Biopure Corporation Sucedaneo de sangre semisintetico extrapuro.
US5084558A (en) * 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4980058A (en) * 1987-11-06 1990-12-25 Bio-Rad Laboratories, Inc. Separation of hemoglobin A2 from hemoglobin mixture
US5051353A (en) * 1988-08-09 1991-09-24 The United States Of America As Represented By The Secretary Of The Navy Preservation and restoration of hemoglobin in blood substitutes
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
US5250665A (en) * 1991-05-31 1993-10-05 The University Of Toronto Innovations Foundation Specifically β-β cross-linked hemoglobins and method of preparation
AU668294B2 (en) * 1993-03-16 1996-04-26 Hemosol Inc. Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides
US5952470A (en) * 1995-06-07 1999-09-14 Biopure Corporation Method for separating unmodified hemoglobin from cross-linked hemoglobin

Also Published As

Publication number Publication date
US20030203350A1 (en) 2003-10-30
DE69606707D1 (de) 2000-03-23
JPH11507336A (ja) 1999-06-29
EP0832131B1 (en) 2000-02-16
WO1996040783A1 (en) 1996-12-19
JP3950477B2 (ja) 2007-08-01
US20050143565A1 (en) 2005-06-30
DE69606707T2 (de) 2000-11-16
US5952470A (en) 1999-09-14
CA2222679C (en) 2010-08-17
CA2222679A1 (en) 1996-12-19
ATE189819T1 (de) 2000-03-15
EP0832131A1 (en) 1998-04-01
AU6094396A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
MX9707909A (es) Purificacion de anticuerpos.
ES2142590T3 (es) Separacion de hemoglobina no modificada de hemoglobina reticulada.
DE3273613D1 (en) Hydrogen diffusion membrane and process for separating hydrogen from gas mixtures by diffusion
DE3668157D1 (de) Hybrid-membran/kryogenverfahren zur reinigung von wasserstoff.
EA199900540A1 (ru) Усовершенствованный способ извлечения олефинов из крекинг-газов с использованием процесса химической абсорбции
TW357104B (en) Perfluorocompound separation and purification method and system
GB2099446B (en) Process for separating acid gases from hydrocarbons
ES2155477T3 (es) Purificacion cromatografica y procedimiento de separacion de acidos nucleicos.
PL374311A1 (en) Methods for purifying protein
NO913186D0 (no) Fremgangsmaate for anvendelse og syntese av peptider.
AR228060A1 (es) Procedimiento de preparacion de membrana de fibra hueca porosa para la separacion de plasma
DK0832097T3 (da) System og fremgangsmåde til modifikation og rensning af peptider
EP0131142A3 (en) Process for recovering a cell wall protein
ATE34177T1 (de) Verfahren zur gewinnung einer peptidbindungen enthaltenden verbindung.
AU5718898A (en) Process for selectively separating hydrogen, or both hydrogen and carbon monoxide from olefinic hydrocarbons
ATE307649T1 (de) Kontinuierliches verfahren zur trennung von stoffen nach molekülgrösse
DK0646594T3 (da) Fremgangsmåde til rensning af proteiner
DE3169877D1 (en) Process for eliminating acid gases, especially carbon dioxyde, from gaseous mixtures
MX9709312A (es) Metodo para purificar trombopoyetina.
HK1047754B (zh) 將膠原從血漿蛋白中隔離
EP0727226A3 (de) Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
MY119738A (en) Process for the purification of an alkanolamine
EP0333474A3 (en) Process for the selective removal of endotoxin
CA2058948A1 (en) Processes for the recovery of naturally produced chymosin
BR9707350A (pt) Recuperação de natamicina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 832131

Country of ref document: ES